GlassScriptPhysician profile
John C Chaloupka
NPI 1679564892
$209,462.54
in general payments reported to CMS, 2019-2025
25 companies · $37K in 2025
The $37K reported for 2025 was more than what 96% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $29K · 2021: $13K · 2022: $26K · 2023: $25K · 2024: $65K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $47K · Consulting Fee: $31K · Travel and Lodging: $30K · Food and Beverage: $18K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $47,350.00 |
| Consulting Fee | $31,350.00 |
| Travel and Lodging | $30,372.44 |
| Food and Beverage | $17,591.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $123,136.28 | 2019-2025 | Stent, Web Aneurysm Embolization System, Lvis Junior |
| Penumbra, INC. | $52,868.54 | 2019-2025 | Penumbra System, Benchmark, Red 72 |
| Stryker Corporation | $13,357.91 | 2019-2025 | Trevo, Surpass Evolve, Augment Injectable |
| Siemens Medical Solutions USA, INC. | $9,196.80 | 2019 | |
| Medical Device Business Services, INC. | $4,360.29 | 2023-2025 | Emboguard, Trufill |
| Sirtex Medical INC | $1,665.54 | 2025 | Lava Les (Liquid Embolic System), Sir-Spheres Microspheres |
| Scientia Vascular | $809.62 | 2022-2025 | |
| Rapid Medical LTD | $644.20 | 2021-2023 | Comaneci 17, Tigertriever 17 Revascularization Device |
| Depuy Synthes Sales INC. | $632.29 | 2022-2024 | Embotrap, Cerebase, Cerepak Uniform |
| Medtronic, INC. | $613.49 | 2021-2025 | Pipeline, Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Imperative Care, INC | $441.76 | 2021-2025 | Zoom 88-T Large Distal Platform, Zoom Rdl Radial Access System, 103cm |
| Medtronic USA, INC. | $423.91 | 2019 | |
| Chiesi USA, INC. | $333.20 | 2022-2024 | Cleviprex, Kengreal |
| Balt USA, LLC | $284.92 | 2023-2024 | Optima Coil System |
| Astrazeneca Pharmaceuticals LP | $163.97 | 2021-2023 | Andexxa |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $139.74 | 2023 | Cerepak Uniform |
| Alexion Pharmaceuticals, INC. | $125.88 | 2022 | |
| Qapel Medical INC | $97.44 | 2024 | |
| Integra Lifesciences Corporation | $31.49 | 2019 | |
| Phenox INC. | $29.95 | 2022 | |
| Kci USA, INC. | $28.41 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Si-Bone, INC. | $24.23 | 2022 | |
| Amgen INC. | $20.36 | 2025 | Evenity |
| Arteriocyte Medical Systems, INC. | $19.00 | 2022 | |
| Theragen, INC. | $13.32 | 2024 | Actastim-S |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Chaloupka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.